Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

References for PMC Articles for PubMed (Select 23276253)

1.

Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.

Eriksson BI, Smith JJ, Caprini J, Hantel S, Clemens A, Feuring M, Schnee J, Barsness GW.

Thromb Res. 2012 Sep;130(3):396-402. doi: 10.1016/j.thromres.2012.05.014. Epub 2012 Jun 15.

PMID:
22704461
2.

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.

EINSTEIN–PE Investigators, Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A.

N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26.

3.

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.

Uchino K, Hernandez AV.

Arch Intern Med. 2012 Mar 12;172(5):397-402. doi: 10.1001/archinternmed.2011.1666. Epub 2012 Jan 9. Review.

PMID:
22231617
4.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

5.

Edoxaban: a new oral direct factor xa inhibitor.

Camm AJ, Bounameaux H.

Drugs. 2011 Aug 20;71(12):1503-26. doi: 10.2165/11595540-000000000-00000.

PMID:
21861537
6.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

7.

The business case for quality improvement: oral anticoagulation for atrial fibrillation.

Rose AJ, Berlowitz DR, Ash AS, Ozonoff A, Hylek EM, Goldhaber-Fiebert JD.

Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):416-24. doi: 10.1161/CIRCOUTCOMES.111.960591. Epub 2011 Jun 28.

8.

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.

Wieloch M, Själander A, Frykman V, Rosenqvist M, Eriksson N, Svensson PJ.

Eur Heart J. 2011 Sep;32(18):2282-9. doi: 10.1093/eurheartj/ehr134. Epub 2011 May 26.

9.

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A.

BMJ. 2011 Feb 24;342:d813. doi: 10.1136/bmj.d813. Review.

10.

A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.

Meijer K, Kim YK, Carter D, Schulman S.

Thromb Haemost. 2011 Feb;105(2):232-8. doi: 10.1160/TH10-05-0324. Epub 2010 Dec 21.

PMID:
21173999
11.

Oral rivaroxaban for symptomatic venous thromboembolism.

EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S.

N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3.

12.

Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.

Deitelzweig SB, Lin J, Kreilick C, Hussein M, Battleman D.

Adv Ther. 2010 Sep;27(9):623-33. doi: 10.1007/s12325-010-0056-z. Epub 2010 Jul 30.

PMID:
20680533
13.

Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.

Carrier M, Le Gal G, Wells PS, Rodger MA.

Ann Intern Med. 2010 May 4;152(9):578-89. doi: 10.7326/0003-4819-152-9-201005040-00008. Review.

PMID:
20439576
14.

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ; RE-COVER Study Group.

N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598. Epub .

15.

Anticoagulant therapy for acute venous thromboembolism: what we think we know and what the data show for the timing of recurrent events.

Stein PD, Hull RD, Matta F, Yaekoub AY.

Clin Appl Thromb Hemost. 2009 Dec;15(6):609-12. doi: 10.1177/1076029609349500. Epub 2009 Oct 13. Review.

PMID:
19825911
16.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators.

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

17.

Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study.

Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, Crowther MA, Goldberg RJ.

Thromb Haemost. 2009 May;101(5):878-85.

18.

Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.

Trujillo-Santos J, Ruiz-Gamietea A, Luque JM, Samperiz AL, Garcia-Bragado F, Todoli JA, Monreal M; RIETE Investigators.

Thromb Res. 2009;123 Suppl 2:S10-5. doi: 10.1016/S0049-3848(09)70003-9.

PMID:
19217463
19.

Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.

Nieto JA, Camara T, Gonzalez-Higueras E, Ruiz-Gimenez N, Guijarro R, Marchena PJ, Monreal M; RIETE Investigators.

Thromb Haemost. 2008 Nov;100(5):789-96.

PMID:
18989522
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk